425 related articles for article (PubMed ID: 34948224)
1. Hippo Pathway in Regulating Drug Resistance of Glioblastoma.
Casati G; Giunti L; Iorio AL; Marturano A; Galli L; Sardi I
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948224
[TBL] [Abstract][Full Text] [Related]
2. Hippo Signaling Pathway in Gliomas.
Masliantsev K; Karayan-Tapon L; Guichet PO
Cells; 2021 Jan; 10(1):. PubMed ID: 33477668
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective.
Samji P; Rajendran MK; Warrier VP; Ganesh A; Devarajan K
Cell Signal; 2021 Feb; 78():109858. PubMed ID: 33253912
[TBL] [Abstract][Full Text] [Related]
5. Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ.
Liu Z; Wei Y; Zhang L; Yee PP; Johnson M; Zhang X; Gulley M; Atkinson JM; Trebak M; Wang HG; Li W
Oncogene; 2019 Jan; 38(1):120-139. PubMed ID: 30082911
[TBL] [Abstract][Full Text] [Related]
6. FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases.
Xu Y; Wang K; Yu Q
Oncotarget; 2016 Oct; 7(43):70080-70091. PubMed ID: 27661120
[TBL] [Abstract][Full Text] [Related]
7. Hippo/YAP signaling choreographs the tumor immune microenvironment to promote triple negative breast cancer progression via TAZ/IL-34 axis.
Wang Z; Wang F; Ding XY; Li TE; Wang HY; Gao YH; Wang WJ; Liu YF; Chen XS; Shen KW
Cancer Lett; 2022 Feb; 527():174-190. PubMed ID: 34929335
[TBL] [Abstract][Full Text] [Related]
8. Silence of Hippo Pathway Associates with Pro-Tumoral Immunosuppression: Potential Therapeutic Target of Glioblastomas.
Kim EH; Sohn BH; Eun YG; Lee DJ; Yim SY; Kang SG; Lee JS
Cells; 2020 Jul; 9(8):. PubMed ID: 32717825
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.
Artinian N; Cloninger C; Holmes B; Benavides-Serrato A; Bashir T; Gera J
J Biol Chem; 2015 Aug; 290(32):19387-401. PubMed ID: 25998128
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.
Zhu G; Wang Y; Mijiti M; Wang Z; Wu PF; Jiafu D
Biochem Biophys Res Commun; 2015 Sep; 465(2):194-9. PubMed ID: 26241672
[TBL] [Abstract][Full Text] [Related]
12. The Hippo Signaling Pathway in Pancreatic Cancer.
Ansari D; Ohlsson H; Althini C; Bauden M; Zhou Q; Hu D; Andersson R
Anticancer Res; 2019 Jul; 39(7):3317-3321. PubMed ID: 31262852
[TBL] [Abstract][Full Text] [Related]
13. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism.
Lee CAA; Banerjee P; Wilson BJ; Wu S; Guo Q; Berg G; Karpova S; Mishra A; Lian JW; Tran J; Emmerich M; Murphy GF; Frank MH; Frank NY
J Biol Chem; 2020 May; 295(22):7774-7788. PubMed ID: 32317280
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in glioblastoma stem-like cells: Role of the hypoxic microenvironment and adenosine signaling.
Uribe D; Torres Á; Rocha JD; Niechi I; Oyarzún C; Sobrevia L; San Martín R; Quezada C
Mol Aspects Med; 2017 Jun; 55():140-151. PubMed ID: 28223127
[TBL] [Abstract][Full Text] [Related]
15. mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics.
Holmes B; Benavides-Serrato A; Saunders JT; Kumar S; Nishimura RN; Gera J
Neoplasia; 2021 Sep; 23(9):951-965. PubMed ID: 34343821
[TBL] [Abstract][Full Text] [Related]
16. CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.
Xu Y; Stamenkovic I; Yu Q
Cancer Res; 2010 Mar; 70(6):2455-64. PubMed ID: 20197461
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
Jang JW; Kim MK; Bae SC
Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of the mammalian Hippo signaling pathway.
Ji XY; Zhong G; Zhao B
Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
[TBL] [Abstract][Full Text] [Related]
19. FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1.
Wang Y; Wang K; Fu J; Zhang Y; Mao Y; Wang X; Wang X; Yu R; Zhou X
Neuro Oncol; 2022 Dec; 24(12):2107-2120. PubMed ID: 35723276
[TBL] [Abstract][Full Text] [Related]
20. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
